Search Results

The Ellex Integre Pro Scan is indicated for use photocoagulation of both anterior and posterior segments of the eye including: - Retinal photocoagulation and pan retinal photocoagulation of vascular and structural . abnormalities of the retina and choroid including: - proliferative and nonproliferative diabetic retinopathy; - choroidal neovascularization; . - retinal vein occlusion; - - - wet age-related macular degeneration; : - retinal tears and detachments; - - retinopathy of prematurity; - - Iridotomy, iridectorny, suturelysis and trabeculoplasty in angle closure glaucoma and open angle . glaucoma

Not Found

The 2RT (LR1532) is indicated for use by a trained ophthalmic physician to produce a wound to the Retinal Pigmented Epithelium (RPE) of the retina of the eye, via focal laser treatment, in the treatment of; Clinically Significant Macular Edema (CSME) .

2RT (model number LR1532) ophthalmic laser system

The Integre family of Ophthalmic laser and Delivery Devices are intended to be used in the treatment of ocular pathology. The Ellex Integre Pro L2RY is indicated for use in photocoagulation of both anterior and posterior segments of the eye including: - Retinal photocoagulation and pan retinal photocoagulation of vascular and structural abnormalities of the retina and choroid including: - proliferative and nonproliferative diabetic retinopathy: - choroidal neovascularization; - branch retinal vein occlusion; - age-related macular degeneration; - retinal tears and detachments: - retinopathy of prematurity; - Iridotomy, iridectorny, suturelysis and trabeculoplasty in angle closure glaucoma and open angle glaucoma

The Integre Pro L2RY is an addition to the Ellex range of ophthalmic photocoagulators. The Integre family are designed for use by ophthalmologists in a clinic or outpatient facility, or in the Retinal Specialist's office. It is capable of producing focused pulses of red or yellow light with wavelengths of 670 nanometres (nm) and 561 nm respectively. The red and vellow beams may be used for the same treatments, but the red gives increased penetration of haemorrhaging tissue and fluids, and may also be used to treat ocular melanomas. The Integre Pro L2RY is based upon the Integre Duo LP1RG with a modification to the laser cavity optical components which results in a yellow (561 nm) treatment laser output. As with the Integre Duo, the laser pulses are accurately positioned on a structure within the patient's eye with the aid of a delivery device. The delivery device is an integrated slit-lamp microscope. An optional Laser Indirect Ophthalmoscope (LIO) can also be used. The Integre Pro is an ophthalmic photocoagulator laser designed to be used by ophthalmologists for treatment of ocular pathology of the eye.

The Ellex Integre is indicated for use in photocoagulation of both anterior and posterior segments of the eye including: - Retinal photocoagulation and pan retinal photocoagulation of vascular and structural abnormalities of the retina and choroid including: - proliferative and nonproliferative diabetic retinopathy; - choroidal neovascularization; - branch retinal vein occlusion; - age-related macular degeneration; - retinal tears and detachments: - retinopathy of prematurity; - Iridotomy, iridectorny, suturelysis and trabeculoplasty in angle closure glaucoma and open angle glaucoma

The Integre LP561 is an addition to the Ellex range of ophthalmic photocoagulators. The Integre family are designed for use by ophthalmologists in a clinic or outpatient facility, or in the Retinal Specialist's office. The Integre Duo LP1RG device is capable of producing focused pulses of red or green light with wavelengths of 670 nanometres (nm) and 532 nm respectively. The red and green beams may be used for the same treatments, but the red gives increased penetration of haemorrhaging tissue and fluids, and may also be used to treat ocular melanomas. The Integre LP561 is essentially the same device with a modification to the laser cavity optical components which results in a vellow (561 nm) treatment laser output. The reason for developing the new device is because the yellow wavelength is characterised by high absorption by melanin in the retinal pigment epithelium and choroids that reduces the penetration depth of the beam in the choroids, high absorption by haemoglobin that facilitates direct treatment for retinal/choroidal neovascularisation and no absorption in macular xanthophylls and higher transmission through cloudy media such as cataract or haze on the cornea. As with the Integre LP1RG, the laser pulses are accurately positioned on a structure within the patient's eye with the aid of a delivery device. The delivery device is an integrated slit-lamp microscope. An optional Laser Indirect Ophthalmoscope (LIO) can also be used.

The Laserex Duo family of dual wavelength ophthalmic lasers are intended for use in the treatment of ocular pathology. The Laserex Duo is indicated for use in photocoagulation of both anterior and posterior segments of the eye including: - Retinal photocoagulation and pan retinal photocoagulation of vascular and . structural abnormalities of the retina and choroid including: - proliferative and nonproliferative diabetic retinopathy; - - choroidal neovascularization; - - branch retinal vein occlusion; - - age-related macular degeneration; - retinal tears and detachments; - - retinopathy of prematurity; - - Iridotomy, iridectomy, suturelysis and trabeculoplasty in angle closure glaucoma . and open angle glaucoma

Not Found

The Laserex LP4532 Ophthalmic Laser is intended for use in the treatment of ocular pathology The Laserex LP4532 is indicated for use in photocoagulation of both anterior and posterior segments of the eye including: - Retinal photocoagulation, pan retinal photocoagulation and intravitreal endophotocognilation of vascular and structural abnormalities of the retina and choroid including: - proliferative and nonproliferative diabetic retinopathy: - choroidal neovascularization; - branch retinal vein occlusion; - age-refated macular degeneration; - retinal tears and detachments; - retinopathy of prematurity; - macular grid; - macular focal; - Iridotomy, tridectorny, suturelysis and trabeculoplasty in angle closure glaucoma and open angle glaucoma

Not Found

CAPSULOTOMY POSTERIOR IRIDOTOMY / IRIDECTOMY POSTERIOR MEMBRANECTOMY SELECTIVE LASER TRABELULOPLASTY (SLT)

Not Found

The indications for use for the above product family is: - Iridectomy/Iridotomy. - Posterior Capsulotomy. - Posterior Membranectomies.

Not Found

The indication for use for this product are; - · Retinal Photocoagulation - · Pan Retinal Photocoagulation - · Photocoaqulation for Macular Degeneration · Laser Trabeculoplasty - - · Endophotocoagulation.

The LP1532 is a compact, solid state laser photocoagulator intended for ophthalmic use. It produces laser energy intended to be directed into the eye by a suitably qualified physician, via a range of laser delivery accessories namely; - Laser Endoprobes . - Laser Indirect Ophthalmoscope . - Slitlamp Delivery Systems . The LP1532 is a frequency doubled Nd:YAG Laser operating in the visible green wavelength spectrum ( 532 nanometers ).